Home › Companies › CLEARPOINT NEURO INC. › 2024-2025
At CLEARPOINT NEURO INC.'s shareholder meeting held May 21, 2025, in the 2024-2025 proxy season, 78 asset managers reported how they voted in their SEC Form N-PX filings, covering 492 separate fund positions. Their filings are grouped here into 13 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — An advisory (non-binding) vote to approve the compensation of ClearPoint Neuro, Inc.'s named… — FOR was 96% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CLEARPOINT NEURO INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 23, 2025.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and CLEARPOINT NEURO INC.’s Form 8-K, filed May 23, 2025 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of May 21, 2025: 12 items on CLEARPOINT NEURO INC.’s Form 8-K, filed May 23, 2025: 8 elected · 3 approved · 1 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore CLEARPOINT NEURO INC. in the interactive database Compare manager voting policies
These tallies are CLEARPOINT NEURO INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 23, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Joseph M. Burnett | 9,980,965 | -- | -- | 72,122 | 8,647,207 | 99.2% | Elected | — |
| Elect Director: R. John Fletcher | 9,408,193 | -- | -- | 644,894 | 8,647,207 | 94% | Elected | — |
| Elect Director: Lynnette C. Fallon | 9,909,422 | -- | -- | 143,665 | 8,647,207 | 99% | Elected | — |
| Elect Director: Pascal E.R. Girin | 9,493,577 | -- | -- | 559,510 | 8,647,207 | 94% | Elected | — |
| Elect Director: B. Kristine Johnson | 9,912,410 | -- | -- | 140,677 | 8,647,207 | 99% | Elected | — |
| Elect Director: Matthew B. Klein | 9,971,122 | -- | -- | 81,965 | 8,647,207 | 99.1% | Elected | — |
| Elect Director: Linda M. Liau | 9,959,656 | -- | -- | 93,431 | 8,647,207 | 99.0% | Elected | — |
| Elect Director: Timothy T. Richards | 9,499,321 | -- | -- | 553,766 | 8,647,207 | 94% | Elected | — |
| 2. The ratification of the appointment of Cherry Bekaert LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025 | 18,622,225 | 5,113 | 72,956 | -- | -- | 99.9% | Approved | — |
| 3. Advisory approval of executive compensation | 9,385,298 | 351,323 | 316,466 | -- | 8,647,207 | 96% | Not verified | — |
| 5. The approval of the Company's Amended and Restated 2021 Employee Stock Purchase Plan; and | 8,721,158 | 1,074,535 | 257,394 | -- | 8,647,207 | 89% | Approved | — |
| 6. The approval of the Company's Sixth Amended and Restated 2013 Incentive Compensation Plan | 8,440,784 | 1,309,359 | 302,944 | -- | 8,647,207 | 87% | Approved | — |
Source: CLEARPOINT NEURO INC., Form 8-K, filed with the SEC on May 23, 2025 — read the filing on EDGAR.
Each item below shows how the 78 asset managers that disclosed a CLEARPOINT NEURO INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of CLEARPOINT NEURO INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: B. Kristine Johnson
CLEARPOINT NEURO INC.’s own tally for this item (“Elect Director: B. Kristine Johnson”): 9,912,410 for, 140,677 withheld, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following named persons were elected as directors of the Company to serve until the 2026 annual meeting of stockholders or until their successors have been duly elected and qualified or until their earlier death, resignation, disqualification or removal.”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 16 asset managers below reported 1,749,567 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,272,886 | 0 | 0 | 0 | For |
| Fidelity | 248,698 | 0 | 0 | 0 | For |
| 1290 Funds | 70,908 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 66,992 | 0 | 0 | 0 | For |
| PFS FUNDS | 46,770 | 0 | 0 | 0 | For |
| T. Rowe Price | 13,500 | 0 | 0 | 0 | For |
| Charles Schwab | 10,369 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,276 | 0 | 0 | 0 | For |
| Equitable | 4,807 | 0 | 0 | 0 | For |
| Victory Capital | 2,887 | 0 | 0 | 0 | For |
| BlackRock | 2,541 | 0 | 0 | 0 | For |
| Lazard | 2,163 | 0 | 0 | 0 | For |
| John Hancock | 447 | 0 | 0 | 0 | For |
| State Street | 146 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 111 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 66 | 0 | 0 | 0 | For |
Combines 4 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Joseph M. Burnett
CLEARPOINT NEURO INC.’s own tally for this item (“Elect Director: Joseph M. Burnett”): 9,980,965 for, 72,122 withheld, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following named persons were elected as directors of the Company to serve until the 2026 annual meeting of stockholders or until their successors have been duly elected and qualified or until their earlier death, resignation, disqualification or removal.”
Support: 99.2% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 16 asset managers below reported 1,749,567 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,272,886 | 0 | 0 | 0 | For |
| Fidelity | 248,698 | 0 | 0 | 0 | For |
| 1290 Funds | 70,908 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 66,992 | 0 | 0 | 0 | For |
| PFS FUNDS | 46,770 | 0 | 0 | 0 | For |
| T. Rowe Price | 13,500 | 0 | 0 | 0 | For |
| Charles Schwab | 10,369 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,276 | 0 | 0 | 0 | For |
| Equitable | 4,807 | 0 | 0 | 0 | For |
| Victory Capital | 2,887 | 0 | 0 | 0 | For |
| BlackRock | 2,541 | 0 | 0 | 0 | For |
| Lazard | 2,163 | 0 | 0 | 0 | For |
| John Hancock | 447 | 0 | 0 | 0 | For |
| State Street | 146 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 111 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 66 | 0 | 0 | 0 | For |
Combines 4 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Linda M. Liau
CLEARPOINT NEURO INC.’s own tally for this item (“Elect Director: Linda M. Liau”): 9,959,656 for, 93,431 withheld, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following named persons were elected as directors of the Company to serve until the 2026 annual meeting of stockholders or until their successors have been duly elected and qualified or until their earlier death, resignation, disqualification or removal.”
Support: 99.0% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 16 asset managers below reported 1,749,567 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,272,886 | 0 | 0 | 0 | For |
| Fidelity | 248,698 | 0 | 0 | 0 | For |
| 1290 Funds | 70,908 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 66,992 | 0 | 0 | 0 | For |
| PFS FUNDS | 46,770 | 0 | 0 | 0 | For |
| T. Rowe Price | 13,500 | 0 | 0 | 0 | For |
| Charles Schwab | 10,369 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,276 | 0 | 0 | 0 | For |
| Equitable | 4,807 | 0 | 0 | 0 | For |
| Victory Capital | 2,887 | 0 | 0 | 0 | For |
| BlackRock | 2,541 | 0 | 0 | 0 | For |
| Lazard | 2,163 | 0 | 0 | 0 | For |
| John Hancock | 447 | 0 | 0 | 0 | For |
| State Street | 146 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 111 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 66 | 0 | 0 | 0 | For |
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Lynnette C. Fallon
CLEARPOINT NEURO INC.’s own tally for this item (“Elect Director: Lynnette C. Fallon”): 9,909,422 for, 143,665 withheld, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following named persons were elected as directors of the Company to serve until the 2026 annual meeting of stockholders or until their successors have been duly elected and qualified or until their earlier death, resignation, disqualification or removal.”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 16 asset managers below reported 1,749,567 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,272,886 | 0 | 0 | 0 | For |
| Fidelity | 248,698 | 0 | 0 | 0 | For |
| 1290 Funds | 70,908 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 66,992 | 0 | 0 | 0 | For |
| PFS FUNDS | 46,770 | 0 | 0 | 0 | For |
| T. Rowe Price | 13,500 | 0 | 0 | 0 | For |
| Charles Schwab | 10,369 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,276 | 0 | 0 | 0 | For |
| Equitable | 4,807 | 0 | 0 | 0 | For |
| Victory Capital | 2,887 | 0 | 0 | 0 | For |
| BlackRock | 2,541 | 0 | 0 | 0 | For |
| Lazard | 2,163 | 0 | 0 | 0 | For |
| John Hancock | 447 | 0 | 0 | 0 | For |
| State Street | 146 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 111 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 66 | 0 | 0 | 0 | For |
Combines 4 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Matthew B. Klein
CLEARPOINT NEURO INC.’s own tally for this item (“Elect Director: Matthew B. Klein”): 9,971,122 for, 81,965 withheld, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following named persons were elected as directors of the Company to serve until the 2026 annual meeting of stockholders or until their successors have been duly elected and qualified or until their earlier death, resignation, disqualification or removal.”
Support: 99.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 16 asset managers below reported 1,749,567 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,272,886 | 0 | 0 | 0 | For |
| Fidelity | 248,698 | 0 | 0 | 0 | For |
| 1290 Funds | 70,908 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 66,992 | 0 | 0 | 0 | For |
| PFS FUNDS | 46,770 | 0 | 0 | 0 | For |
| T. Rowe Price | 13,500 | 0 | 0 | 0 | For |
| Charles Schwab | 10,369 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,276 | 0 | 0 | 0 | For |
| Equitable | 4,807 | 0 | 0 | 0 | For |
| Victory Capital | 2,887 | 0 | 0 | 0 | For |
| BlackRock | 2,541 | 0 | 0 | 0 | For |
| Lazard | 2,163 | 0 | 0 | 0 | For |
| John Hancock | 447 | 0 | 0 | 0 | For |
| State Street | 146 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 111 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 66 | 0 | 0 | 0 | For |
Combines 4 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Pascal E.R. Girin
CLEARPOINT NEURO INC.’s own tally for this item (“Elect Director: Pascal E.R. Girin”): 9,493,577 for, 559,510 withheld, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following named persons were elected as directors of the Company to serve until the 2026 annual meeting of stockholders or until their successors have been duly elected and qualified or until their earlier death, resignation, disqualification or removal.”
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 16 asset managers below reported 1,749,390 for, 111 withheld, 66 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,272,886 | 0 | 0 | 0 | For |
| Fidelity | 248,698 | 0 | 0 | 0 | For |
| 1290 Funds | 70,908 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 66,992 | 0 | 0 | 0 | For |
| PFS FUNDS | 46,770 | 0 | 0 | 0 | For |
| T. Rowe Price | 13,500 | 0 | 0 | 0 | For |
| Charles Schwab | 10,369 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,276 | 0 | 0 | 0 | For |
| Equitable | 4,807 | 0 | 0 | 0 | For |
| Victory Capital | 2,887 | 0 | 0 | 0 | For |
| BlackRock | 2,541 | 0 | 0 | 0 | For |
| Lazard | 2,163 | 0 | 0 | 0 | For |
| John Hancock | 447 | 0 | 0 | 0 | For |
| State Street | 146 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 111 | Withhold |
| Innovator ETFs Trust | 0 | 0 | 66 | 0 | Abstain |
Combines 4 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: R. John Fletcher
CLEARPOINT NEURO INC.’s own tally for this item (“Elect Director: R. John Fletcher”): 9,408,193 for, 644,894 withheld, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following named persons were elected as directors of the Company to serve until the 2026 annual meeting of stockholders or until their successors have been duly elected and qualified or until their earlier death, resignation, disqualification or removal.”
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 16 asset managers below reported 1,747,227 for, 2,274 withheld, 66 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,272,886 | 0 | 0 | 0 | For |
| Fidelity | 248,698 | 0 | 0 | 0 | For |
| 1290 Funds | 70,908 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 66,992 | 0 | 0 | 0 | For |
| PFS FUNDS | 46,770 | 0 | 0 | 0 | For |
| T. Rowe Price | 13,500 | 0 | 0 | 0 | For |
| Charles Schwab | 10,369 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,276 | 0 | 0 | 0 | For |
| Equitable | 4,807 | 0 | 0 | 0 | For |
| Victory Capital | 2,887 | 0 | 0 | 0 | For |
| BlackRock | 2,541 | 0 | 0 | 0 | For |
| Lazard | 0 | 0 | 0 | 2,163 | Withhold |
| John Hancock | 447 | 0 | 0 | 0 | For |
| State Street | 146 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 111 | Withhold |
| Innovator ETFs Trust | 0 | 0 | 66 | 0 | Abstain |
Combines 4 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Timothy T. Richards
CLEARPOINT NEURO INC.’s own tally for this item (“Elect Director: Timothy T. Richards”): 9,499,321 for, 553,766 withheld, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following named persons were elected as directors of the Company to serve until the 2026 annual meeting of stockholders or until their successors have been duly elected and qualified or until their earlier death, resignation, disqualification or removal.”
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 16 asset managers below reported 1,749,390 for, 111 withheld, 66 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,272,886 | 0 | 0 | 0 | For |
| Fidelity | 248,698 | 0 | 0 | 0 | For |
| 1290 Funds | 70,908 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 66,992 | 0 | 0 | 0 | For |
| PFS FUNDS | 46,770 | 0 | 0 | 0 | For |
| T. Rowe Price | 13,500 | 0 | 0 | 0 | For |
| Charles Schwab | 10,369 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,276 | 0 | 0 | 0 | For |
| Equitable | 4,807 | 0 | 0 | 0 | For |
| Victory Capital | 2,887 | 0 | 0 | 0 | For |
| BlackRock | 2,541 | 0 | 0 | 0 | For |
| Lazard | 2,163 | 0 | 0 | 0 | For |
| John Hancock | 447 | 0 | 0 | 0 | For |
| State Street | 146 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 111 | Withhold |
| Innovator ETFs Trust | 0 | 0 | 66 | 0 | Abstain |
Combines 2 wordings of this item as funds reported it.
89% Approved · of votes cast
Description as filed by funds: Approval of ClearPoint Neuro, Inc.'s Amended and Restated 2021 Employee Stock Purchase Plan.
CLEARPOINT NEURO INC.’s own tally for this item (“5. The approval of the Company's Amended and Restated 2021 Employee Stock Purchase Plan; and”): 8,721,158 for, 1,074,535 against — passed, per its Form 8-K filed May 23, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders approved the Company's Amended and Restated 2021 Employee Stock Purchase Plan.”
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 16 asset managers below reported 1,749,567 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,272,886 | 0 | 0 | 0 | For |
| Fidelity | 248,698 | 0 | 0 | 0 | For |
| 1290 Funds | 70,908 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 66,992 | 0 | 0 | 0 | For |
| PFS FUNDS | 46,770 | 0 | 0 | 0 | For |
| T. Rowe Price | 13,500 | 0 | 0 | 0 | For |
| Charles Schwab | 10,369 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,276 | 0 | 0 | 0 | For |
| Equitable | 4,807 | 0 | 0 | 0 | For |
| Victory Capital | 2,887 | 0 | 0 | 0 | For |
| BlackRock | 2,541 | 0 | 0 | 0 | For |
| Lazard | 2,163 | 0 | 0 | 0 | For |
| John Hancock | 447 | 0 | 0 | 0 | For |
| State Street | 146 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 111 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 66 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
87% Approved · of votes cast
Description as filed by funds: Approval of ClearPoint Neuro, Inc.'s Sixth Amended and Restated 2013 Incentive Compensation Plan.
CLEARPOINT NEURO INC.’s own tally for this item (“6. The approval of the Company's Sixth Amended and Restated 2013 Incentive Compensation Plan”): 8,440,784 for, 1,309,359 against — passed, per its Form 8-K filed May 23, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders approved the Company's Sixth Amended and Restated 2013 Incentive Compensation Plan.”
Support: 87% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 16 asset managers below reported 1,749,421 for, 146 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,272,886 | 0 | 0 | 0 | For |
| Fidelity | 248,698 | 0 | 0 | 0 | For |
| 1290 Funds | 70,908 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 66,992 | 0 | 0 | 0 | For |
| PFS FUNDS | 46,770 | 0 | 0 | 0 | For |
| T. Rowe Price | 13,500 | 0 | 0 | 0 | For |
| Charles Schwab | 10,369 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,276 | 0 | 0 | 0 | For |
| Equitable | 4,807 | 0 | 0 | 0 | For |
| Victory Capital | 2,887 | 0 | 0 | 0 | For |
| BlackRock | 2,541 | 0 | 0 | 0 | For |
| Lazard | 2,163 | 0 | 0 | 0 | For |
| John Hancock | 447 | 0 | 0 | 0 | For |
| State Street | 0 | 146 | 0 | 0 | Against |
| Advisors' Inner Circle Fund III | 111 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 66 | 0 | 0 | 0 | For |
Combines 6 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: An advisory (non-binding) vote to approve the compensation of ClearPoint Neuro, Inc.'s named executive officers.
CLEARPOINT NEURO INC.’s own tally for this item (“3. The advisory approval of executive compensation”): 9,385,298 for, 351,323 against, per its Form 8-K filed May 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,272,886 | 0 | 0 | 0 | For |
| Fidelity | 248,698 | 0 | 0 | 0 | For |
| 1290 Funds | 70,908 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 66,992 | 0 | 0 | Against |
| PFS FUNDS | 46,770 | 0 | 0 | 0 | For |
| T. Rowe Price | 13,500 | 0 | 0 | 0 | For |
| Charles Schwab | 10,369 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,276 | 0 | 0 | 0 | For |
| Equitable | 4,807 | 0 | 0 | 0 | For |
| Victory Capital | 2,887 | 0 | 0 | 0 | For |
| BlackRock | 2,541 | 0 | 0 | 0 | For |
| Lazard | 0 | 2,163 | 0 | 0 | Against |
| John Hancock | 447 | 0 | 0 | 0 | For |
| State Street | 146 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 111 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 66 | 0 | 0 | 0 | For |
Fund voting reports, all 16 managers: 1,680,412 for, 69,155 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BROWN ADVISORY INC | 331,095 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 291,246 | 0 | 0 | 0 | For |
| BlackRock | 265,754 | 26 | 0 | 0 | For |
| DE Shaw | 162,275 | 0 | 0 | 0 | For |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 143,901 | 0 | 0 | 0 | For |
| Point72 | 78,352 | 0 | 0 | 0 | For |
| Invesco | 0 | 75,687 | 0 | 0 | Against |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 66,992 | 0 | 0 | Against |
| State Street | 57,402 | 0 | 0 | 0 | For |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 48,339 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 46,512 | 0 | 0 | 0 | For |
| Informed Momentum Co LLC | 39,881 | 0 | 0 | 0 | For |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 35,699 | 0 | 0 | 0 | For |
| AMERIPRISE FINANCIAL INC | 33,689 | 0 | 0 | 0 | For |
| OMERS ADMINISTRATION Corp | 33,000 | 0 | 0 | 0 | For |
| Northern Trust | 26,127 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 26,013 | 0 | 0 | 0 | For |
| Lazard | 0 | 25,738 | 0 | 0 | Against |
| STIFEL NICOLAUS & CO INC \MO\ | 18,222 | 0 | 0 | 0 | For |
| UBS | 0 | 16,036 | 0 | 0 | Against |
| Citadel | 15,224 | 0 | 0 | 0 | For |
| BALYASNY ASSET MANAGEMENT L.P. | 13,891 | 0 | 0 | 0 | For |
| T. Rowe Price | 13,500 | 0 | 0 | 0 | For |
| Vanguard | 11,833 | 0 | 0 | 0 | For |
| Charles Schwab | 10,369 | 0 | 0 | 0 | For |
Institutional-manager reports, all 70 managers: 1,761,224 for, 191,814 against. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
— Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: An advisory (non-binding) vote to set the frequency of future advisory votes on executive compensation.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| 1290 Funds | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 0 | -- |
| PFS FUNDS | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| Victory Capital | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Lazard | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 0 | -- |
| Innovator ETFs Trust | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 16 managers: 1,749,567 1 year.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BROWN ADVISORY INC | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| DE Shaw | 0 | 0 | 0 | 0 | -- |
| Point72 | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0 | 0 | 0 | 0 | -- |
| MARSHALL WACE, LLP | 0 | 0 | 0 | 0 | -- |
| Informed Momentum Co LLC | 0 | 0 | 0 | 0 | -- |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 0 | 0 | 0 | 0 | -- |
| AMERIPRISE FINANCIAL INC | 0 | 0 | 0 | 0 | -- |
| OMERS ADMINISTRATION Corp | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0 | 0 | 0 | 0 | -- |
| Lazard | 0 | 0 | 0 | 0 | -- |
| STIFEL NICOLAUS & CO INC \MO\ | 0 | 0 | 0 | 0 | -- |
| UBS | 0 | 0 | 0 | 0 | -- |
| Citadel | 0 | 0 | 0 | 0 | -- |
| BALYASNY ASSET MANAGEMENT L.P. | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Man Group plc | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 68 managers: 1,808,596 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: Ratification of the appointment of Cherry Bekaert LLP as ClearPoint Neuro, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2025.
CLEARPOINT NEURO INC.’s own tally for this item (“2. The ratification of the appointment of Cherry Bekaert LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025”): 18,622,225 for, 5,113 against — passed, per its Form 8-K filed May 23, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders ratified the appointment of Cherry Bekaert LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 16 asset managers below reported 1,749,567 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,272,886 | 0 | 0 | 0 | For |
| Fidelity | 248,698 | 0 | 0 | 0 | For |
| 1290 Funds | 70,908 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 66,992 | 0 | 0 | 0 | For |
| PFS FUNDS | 46,770 | 0 | 0 | 0 | For |
| T. Rowe Price | 13,500 | 0 | 0 | 0 | For |
| Charles Schwab | 10,369 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,276 | 0 | 0 | 0 | For |
| Equitable | 4,807 | 0 | 0 | 0 | For |
| Victory Capital | 2,887 | 0 | 0 | 0 | For |
| BlackRock | 2,541 | 0 | 0 | 0 | For |
| Lazard | 2,163 | 0 | 0 | 0 | For |
| John Hancock | 447 | 0 | 0 | 0 | For |
| State Street | 146 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 111 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 66 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 27,989,194 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 4.55% |
| 2 | Fidelity | 0.89% |
| 3 | 1290 Funds | 0.25% |
| 4 | BRIDGEWAY FUNDS INC | 0.24% |
| 5 | PFS FUNDS | 0.17% |
| 6 | T. Rowe Price | 0.05% |
| 7 | Charles Schwab | 0.04% |
| 8 | Goldman Sachs | 0.02% |
| 9 | Equitable | 0.02% |
| 10 | Victory Capital | 0.01% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BROWN ADVISORY INC | 1.18% |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | 1.04% |
| 3 | BlackRock | 0.95% |
| 4 | DE Shaw | 0.58% |
| 5 | ESSEX INVESTMENT MANAGEMENT CO LLC | 0.51% |
| 6 | Point72 | 0.28% |
| 7 | Invesco | 0.27% |
| 8 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.24% |
| 9 | State Street | 0.21% |
| 10 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.17% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Bigger Michael | 8.08% | 13G |
| Bigger Capital Fund | 7.33% | DEF14A |
| MAK Capital Fund LP | 6.79% | 13G |
| Vanguard Group | 4.59% | 13F |
| Joseph M. Burnett | 3.03% | DEF14A |
| Millennium Management | 2.65% | 13F |
| BlackRock | 1.47% | 13F |
| Geode Capital | 1.08% | 13F |
| D.E. Shaw | 0.95% | 13F |
| Goldman Sachs | 0.92% | 13F |
Percentages above are of 27,989,194 shares outstanding, as reported by CLEARPOINT NEURO INC. on its Form 10-Q dated May 7, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CLEARPOINT NEURO INC.’s 10-Q dated May 7, 2025. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
CLEARPOINT NEURO INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
proxyvotesnow.com, “CLEARPOINT NEURO (CLPT) 2025 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/clearpoint-neuro-inc/2025 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.